Country Garden Venture Capital led a $66.3m series B2 round for the bioplastic and pathogen detector developer that included Septwolves Venture Capital.

China-based biomanufacturing technology developer Bluepha secured RMB430m ($66.3m) yesterday in a series B2 round led by Country Garden Venture Capital, the corporate venturing arm of real estate developer Country Garden.

Septwolves Venture Capital, a vehicle for apparel producer Septwolves, filled out the round along with Fangyuan Capital, FreesFund, GL Ventures, Huaxing Health Capital, Lightspeed China Partners, Qianhai FOF, Qihang Capital, Taihecap and Trinity Innovation Fund.

Founded in 2016, Bluepha uses synthetic biology, data science and automation to manufacture sustainable materials…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn